Anika Therapeutics, Inc.ANIKNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank64
3Y CAGR-1.4%
5Y CAGR-4.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-1.4%/yr
vs +10.5%/yr prior
5Y CAGR
-4.0%/yr
Consistent
Acceleration
-11.9pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $49.09M | -11.6% |
| 2024 | $55.55M | -7.3% |
| 2023 | $59.92M | +17.0% |
| 2022 | $51.23M | -30.9% |
| 2021 | $74.10M | +23.4% |
| 2020 | $60.06M | +71.9% |
| 2019 | $34.95M | +1.8% |
| 2018 | $34.34M | +59.4% |
| 2017 | $21.54M | +19.6% |
| 2016 | $18.01M | - |